Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in C1 Catamenial Epilepsy
NCT00630630Phase 4Completed
- Sponsor
- UCB
- Start
- Nov 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of levetiracetam in catamenial epilepsy (CE), sponsored by UCB. Started Nov 2002; status: completed.
02
Drugs
levetiracetam
03
Conditions
catamenial epilepsy (CE)
Beyond the preview
Go deeper on NCT00630630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630630.